Animal models for COVID-19

被引：595

作者：

Munoz-Fontela, Cesar ^{[1
,2
]}

Dowling, William E. ^{[3
]}

Funnell, Simon G. P. ^{[4
]}

Gsell, Pierre-S. ^{[5
]}

Riveros-Balta, A. Ximena ^{[5
]}

Albrecht, Randy A. ^{[6
]}

Andersen, Hanne ^{[7
]}

Baric, Ralph S. ^{[8
]}

Carroll, Miles W. ^{[4
]}

Cavaleri, Marco ^{[9
]}

Qin, Chuan ^{[10
]}

Crozier, Ian ^{[11
]}

Dallmeier, Kai ^{[12
]}

de Waal, Leon ^{[13
]}

de Wit, Emmie ^{[14
]}

Delang, Leen ^{[12
]}

Dohm, Erik ^{[15
]}

Duprex, W. Paul ^{[16
]}

Falzarano, Darryl ^{[17
]}

Finch, Courtney L. ^{[18
]}

Frieman, Matthew B. ^{[19
]}

Graham, Barney S. ^{[20
]}

Gralinski, Lisa E. ^{[8
]}

Guilfoyle, Kate ^{[13
]}

Haagmans, Bart L. ^{[21
]}

Hamilton, Geraldine A. ^{[22
]}

Hartman, Amy L. ^{[16
]}

Herfst, Sander ^{[21
]}

Kaptein, Suzanne J. F. ^{[12
]}

Klimstra, William B. ^{[23
]}

Knezevic, Ivana ^{[5
]}

Krause, Philip R. ^{[24
]}

Kuhn, Jens H. ^{[18
]}

Le Grand, Roger ^{[25
]}

Lewis, Mark G. ^{[7
]}

Liu, Wen-Chun ^{[6
]}

Maisonnasse, Pauline ^{[25
]}

McElroy, Anita K. ^{[26
]}

Munster, Vincent ^{[14
]}

Oreshkova, Nadia ^{[27
]}

Rasmussen, Angela L. ^{[28
]}

Rocha-Pereira, Joana ^{[12
]}

Rockx, Barry ^{[21
]}

Rodriguez, Estefania ^{[1
,2
]}

Rogers, Thomas F. ^{[29
]}

Salguero, Francisco J. ^{[4
]}

Schotsaert, Michael ^{[6
]}

Stittelaar, Koert J. ^{[13
]}

Jan Thibaut, Hendrik ^{[12
]}

Tseng, Chien-Te ^{[30
]}

机构：

[1] Bernhard Nocht Inst Trop Med, Hamburg, Germany

[2] German Ctr Infect Res DZIF, Partner Site Hamburg Lubeck Borstel Riems, Hamburg, Germany

[3] Ctr Epidem Preparedness Innovat CEPI, Washington, DC USA

[4] Publ Hlth England, Natl Infect Serv, Salisbury, Wilts, England

[5] WHO, Geneva, Switzerland

[6] Icahn Sch Med Mt Sinai, Dept Microbiol, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA

[7] Bioqual Inc, Rockville, MD USA

[8] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA

[9] European Med Agcy, Amsterdam, Netherlands

[10] Chinese Acad Med Sci & Peking Union Med Coll, Inst Lab Anim Sci, Beijing, Peoples R China

[11] Frederick Natl Lab Canc Res, Clin Monitoring Res Program Directorate, Frederick, MD USA

[12] Katholieke Univ Leuven, Rega Inst, Lab Virol & Chemotherapy, Dept Microbiol Immunol & Transplantat, Leuven, Belgium

[13] Viroclin Xplore, Schaijk, Netherlands

[14] NIAID, Lab Virol, NIH, Hamilton, MT USA

[15] Univ Alabama Birmingham, Anim Resources Program, Birmingham, AL USA

[16] Univ Pittsburgh, Dept Microbiol & Mol Genet, Ctr Vaccine Res, Pittsburgh, PA USA

[17] Univ Saskatchewan, VIDO Intervac, Saskatoon, SK, Canada

[18] NIAID, Integrated Res Facil Ft Detrick, NIH, Frederick, MD USA

[19] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA

[20] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA

[21] Erasmus MC, Dept Virosci, Rotterdam, Netherlands

[22] Emulate Inc, Boston, MA USA

[23] Univ Pittsburgh, Dept Immunol, Ctr Vaccine Res, Pittsburgh, PA USA

[24] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD USA

[25] Univ Paris Saclay, Ctr Immunol Viral Autoimmune Hematol & Bacterial, INSERM, CEA, Paris, France

[26] Univ Pittsburgh, Sch Med, Div Pediat Infect Dis, Ctr Vaccine Res, Pittsburgh, PA USA

[27] Wageningen Univ & Res, Wageningen Biovet Res WBVR, Lelystad, Netherlands

[28] Columbia Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY USA

[29] Univ Calif San Diego, Div Infect Dis, San Diego, CA 92103 USA

[30] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA

[31] Campus Univ Autonoma Barcelona, Ctr Recerca Sanitat Anim CReSA, IRTA UAB, Bellaterra, Spain

[32] Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany

[33] Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Carol Yu Ctr Infect, Hong Kong, Peoples R China

[34] Univ Iowa, Dept Microbiol & Immunol, Iowa City, IA USA

[35] Kansas State Univ, Coll Vet Med, Manhattan, KS 66506 USA

[36] Tulane Natl Primate Res Ctr, Covington, LA USA

[37] UAB, Fac Vet, Dept Sanitat & Anat Anim, Bellaterra, Spain

[38] CSIRO, Australian Ctr Dis Preparedness, Geelong, Vic, Australia

[39] Univ York, Dept Hlth Sci, York, N Yorkshire, England

[40] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02115 USA

来源：

NATURE | 2020年 / 586卷 / 7830期

关键词：

RESPIRATORY SYNDROME CORONAVIRUS; MOUSE MODEL; SARS; INFECTION; MICE; SARS-COV-2; MERS; PATHOGENESIS; RESERVOIRS; EFFICACY;

D O I：

10.1038/s41586-020-2787-6

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the aetiological agent of coronavirus disease 2019 (COVID-19), an emerging respiratory infection caused by the introduction of a novel coronavirus into humans late in 2019 (first detected in Hubei province, China). As of 18 September 2020, SARS-CoV-2 has spread to 215 countries, has infected more than 30 million people and has caused more than 950,000 deaths. As humans do not have pre-existing immunity to SARS-CoV-2, there is an urgent need to develop therapeutic agents and vaccines to mitigate the current pandemic and to prevent the re-emergence of COVID-19. In February 2020, the World Health Organization (WHO) assembled an international panel to develop animal models for COVID-19 to accelerate the testing of vaccines and therapeutic agents. Here we summarize the findings to date and provides relevant information for preclinical testing of vaccine candidates and therapeutic agents for COVID-19. The findings of a World Health Organization expert working group that is developing animal models to test vaccines and therapeutic agents for the treatment of COVID-19, and their relevance for preclinical testing, are reviewed.

引用

页码：509 / 515

页数：7

共 50 条

[41] Cerebrovascular Complications of COVID-19 and COVID-19 Vaccination
De Michele, Manuela
Kahan, Joshua
Berto, Irene
Schiavo, Oscar G.
Iacobucci, Marta
Toni, Danilo
Merkler, Alexander E.
CIRCULATION RESEARCH, 2022, 130 (08) : 1187 - 1203
[42] Status of Novel Coronavirus Disease 2019 (COVID-19) and Animal Production
Defo Deeh, Patrick Brice
Kayri, Veysi
Orhan, Cemal
Sahin, Kazim
FRONTIERS IN VETERINARY SCIENCE, 2020, 7
[43] Characterization of Two Heterogeneous Lethal Mouse-Adapted SARS-CoV-2 Variants Recapitulating Representative Aspects of Human COVID-19
Yan, Feihu
Li, Entao
Wang, Tiecheng
Li, Yuanguo
Liu, Jun
Wang, Weiqi
Qin, Tian
Su, Rina
Pei, Hongyan
Wang, Shen
Feng, Na
Zhao, Yongkun
Yang, Songtao
Xia, Xianzhu
Gao, Yuwei
FRONTIERS IN IMMUNOLOGY, 2022, 13
[44] Human models for COVID-19 research
Woodall, Maximillian N. J.
Masonou, Tereza
Case, Katie-Marie
Smith, Claire M.
JOURNAL OF PHYSIOLOGY-LONDON, 2021, 599 (18): : 4255 - 4267
[45] Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal models
Kalnin, Kirill, V
Plitnik, Timothy
Kishko, Michael
Zhang, Jinrong
Zhang, Donghui
Beauvais, Adrien
Anosova, Natalie G.
Tibbitts, Tim
DiNapoli, Josh
Ulinski, Gregory
Piepenhagen, Peter
Cummings, Sheila M.
Bangari, Dinesh S.
Ryan, Susan
Huang, Po-Wei D.
Huleatt, James
Vincent, Deanne
Fries, Katherine
Karve, Shrirang
Goldman, Rebecca
Gopani, Hardip
Dias, Anusha
Khang Tran
Zacharia, Minnie
Gu, Xiaobo
Boeglin, Lianne
Abysalh, Jonathan
Vargas, Jorel
Beaulieu, Angela
Shah, Monic
Jeannotte, Travis
Gillis, Kimberly
Chivukula, Sudha
Swearingen, Ron
Landolfi, Victoria
Fu, Tong-Ming
DeRosa, Frank
Casimiro, Danilo
NPJ VACCINES, 2021, 6 (01)
[46] Current therapies under investigation for COVID 19: potential COVID-19 treatments
Weisberg, Ellen
Sattler, Martin
Yang, Priscilla L.
Parent, Alexander
Gray, Nathanael
Griffin, James D.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2020, 98 (08) : 483 - 489
[47] Natural and genetically-modified animal models to investigate pulmonary and extrapulmonary manifestations of COVID-19
Tiwari, Shikha
Goel, Garima
Kumar, Ashok
INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2024, 43 (01) : 13 - 32
[48] Drawing parallels between SARS, MERS, and COVID-19: A comparative overview of epidemiology, pathogenesis, and pathological features
Pustake, Manas
Giri, Purushottam
Ganiyani, Mohammad Arfat
Mumtaz, Kahkashan
Deshmukh, Krishna
Saju, Michael
Nunez, Judith Vasquez
Orlova, Natalia
Das, Arghadip
INDIAN JOURNAL OF COMMUNITY MEDICINE, 2023, 48 (04) : 518 - 524
[49] Current treatment strategies for COVID-19
Han, Fabin
Liu, Yanming
Mo, Mei
Chen, Juanli
Wang, Cheng
Yang, Yong
Wu, Jibiao
MOLECULAR MEDICINE REPORTS, 2021, 24 (06)
[50] Cyclosporine and COVID-19: Risk or favorable?
Poulsen, Nadia Nicholine
von Brunn, Albrecht
Hornum, Mads
Blomberg Jensen, Martin
AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 (11) : 2975 - 2982

← 1 2 3 4 5 →